Atlas Trials

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

Clinical trial NCT03164486 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03164486
Sponsor
Julie L. Sutcliffe, Ph.D
Status
ACTIVE_NOT_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Breast CarcinomaColorectal CarcinomaLung CarcinomaMetastatic Malignant Neoplasm in the BreastMetastatic Malignant Neoplasm in the ColonMetastatic Malignant Neoplasm in the LungMetastatic Malignant Neoplasm in the RectumPancreatic Carcinoma
Start date
2016-11-01
Primary completion
2026-12-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.